Importance Dabigatran and rivaroxaban are non–vitamin K oral anticoagulants approved
for stroke prevention in patients with nonvalvular atrial fibrillation (AF). There are no …

Background Several passive surveillance systems reported increased risks of myocarditis or
pericarditis, or both, after COVID-19 mRNA vaccination, especially in young men. We used …

… Goulding PhD a , Yoganand Chillarige MPA c , Mary Ross Southworth PharmD d ,
Thomas E. MaCurdy PhD c e , Jeffrey A. Kelman MD, MMSc f …

Background The low influenza vaccine effectiveness (VE) observed during the A(H3N2)-dominated
2017–2018 season may be due to vaccine virus adaptation to growth in eggs. We …

Background. Recipients of high-dose vs standard-dose influenza vaccines have fewer
influenza illnesses. We evaluated the comparative effectiveness of high-dose vaccine in …

Background The current study was performed to evaluate risk factors for severe coronavirus
disease 2019 (COVID-19) outcomes among Medicare beneficiaries during the pandemic’s …

Background Approximately 50 000 influenza-associated deaths occur annually in the United
States, overwhelmingly among individuals aged ≥65 years. Although vaccination is the …

Background Shingrix (recombinant zoster vaccine) was licensed to prevent herpes zoster,
dispensed as 2 doses given 2–6 months apart among adults aged ≥50 years. Clinical trials …

Background Studies among individuals ages ≥65 years have found a moderately higher
relative vaccine effectiveness (RVE) for the high-dose (HD) influenza vaccine compared with …

Importance Active monitoring of health outcomes after COVID-19 vaccination offers early
detection of rare outcomes that may not be identified in prelicensure trials. Objective To conduct …